首页> 外文期刊>Journal of Polymers and the Environment >Effect of Both Lovastatin and Ginsenoside Rb1 on Some Properties and In-Vitro Drug Release of Alginate/Chitosan/Lovastatin/Ginsenoside Rb1 Composite Films
【24h】

Effect of Both Lovastatin and Ginsenoside Rb1 on Some Properties and In-Vitro Drug Release of Alginate/Chitosan/Lovastatin/Ginsenoside Rb1 Composite Films

机译:洛伐他汀和人参皂苷Rb1均对藻酸盐/壳聚糖/洛伐他汀/人参皂苷Rb1复合膜某些性质和体外药物释放的影响

获取原文
获取原文并翻译 | 示例
           

摘要

This article reports the interactions between lovastatin-a drug for treatment of reducing cholesterol and ginsenoside Rb1-a active substance extracted from Panax ginseng as model drugs loaded by alginate/chitosan blend. The polymer composite films based on chitosan (CS), alginate (AG), lovastatin (Lov) and ginsenoside Rb1 were prepared by solution method with the ratio of AG/CS fixed at 4/1, the content of Rb1 fixed at 5 wt% and content of Lov changed from 5 to 20 wt% in comparison with the weight of CS and AG. The morphology, structure and thermal behavior of alginate/chitosan blend loading both lovastatin and ginsenoside Rb1 were investigated by Fourier transform infrared spectroscopy, scanning electron microscopy, and differential scanning calorimetry methods. Besides, the in-vitro drug release study of lovastatin and ginsenoside Rb1 from AG/CS blend was carried out in different pH buffer solutions for 32 h. The ultraviolet-visible spectra showed two adsorbed peaks corresponding to the optical adsorption of lovastatin and ginsenoside Rb1. The data of drug release content confirmed that lovastatin and ginsenoside Rb1 could affect to each other on drug release from the composite films. The drug release kinetics of lovastatin and ginsenoside Rb1 from the composite films in different pH buffer solutions were also determined to evaluate the interactions between lovastatin and ginsenoside Rb1 fully.
机译:本文报道了用于治疗胆固醇的洛伐他汀与人参皂甙Rb1的相互作用。人参皂甙Rb1是从人参提取的活性物质,藻酸盐/壳聚糖共混物可作为模型药物。采用固溶法制备了基于壳聚糖(CS),藻酸盐(AG),洛伐他汀(Lov)和人参皂苷Rb1的聚合物复合膜,AG / CS的比例固定为4/1,Rb1的含量固定为5 wt%与CS和AG的重量相比,Lov的含量从5 wt%变为20 wt%。通过傅里叶变换红外光谱,扫描电子显微镜和差示扫描量热法研究了装载洛伐他汀和人参皂苷Rb1的藻酸盐/壳聚糖共混物的形态,结构和热行为。此外,在不同pH缓冲溶液中对洛伐他汀和人参皂苷Rb1从AG / CS混合物中的体外释药研究进行了32 h。紫外可见光谱显示出两个吸附峰,分别对应于洛伐他汀和人参皂苷Rb1的光学吸附。药物释放含量的数据证实,洛伐他汀和人参皂苷Rb1可能相互影响复合膜的药物释放。还确定了洛伐他汀和人参皂苷Rb1在不同pH缓冲溶液中从复合膜中释放的动力学,以全面评估洛伐他汀和人参皂苷Rb1之间的相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号